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SIGNIFICANCE OF PEROXIDASE IN EOSINOPHILS
M a r g a ret  A . K e lsa ll
Peroxidase-bearing granules are the primary component and product of eosino­
phils. The physiological significance of eosinophils is, therefore, considered to be 
related to the ability of this cell to synthesize, store, and transport peroxidase and 
to release the peroxidase-positive granules into body fluids by a lytic process that 
is controlled by hormones, by variations in the histamine-epinephrine balance, 
and by several other stimuli. Peroxidase occurs not only in eosinophils, but also 
in neutrophils and blood platelets; but it is not present in most cells of animal 
tissues.
The purpose of this work is to consider, as a working hypothesis, that the 
function of eosinophils is to produce, store, and transport peroxidase to catalyze 
oxidations. Many of the aerobic dehydrogenases that catalyze reactions in which 
hydrogen peroxide is produced are involved in protein catabolism. Therefore, 
relations between eosinophils and several normal and pathological conditions of 
increased protein catabolism are emphasized, and also the significance of peroxi­
dase in eosinophils and other leukocytes to H20 2 produced by irradiation is 
considered.
The functions of eosinophils and peroxidases are difficult to establish experi­
mentally, because other leukocytes and platelets contain peroxidase, and because 
several peroxidatic reactions can be catalyzed by hemoglobin and cytochromes 
(335), and because catalase, which decomposes H20 2, is present in erythrocytes 
and other cells, thereby preventing accumulation of H20 2 (616). In addition, 
catalase can act as a peroxidase in oxidation of alcohols (247) and large amounts 
of catalase cause purely oxidative effects, in contrast to the predominance of 
peroxidase activity when only small amounts of catalase are present (558). Further­
more, Keilen and Hartree have suggested that catalase may have a peroxidative 
function in most cells instead of preventing accumulation of H20 2 (74).
P ero xid ase  G ran u les
The eosinophil is one of the few types of cells which contain peroxidase and 
is the only cell which has its cytoplasm filled with large peroxidase-positive granules 
which are widely dispersed upon lysis of the cell. One function of eosinophils is the 
synthesis and storage of peroxidase within a cell and the release of this enzyme 
when and where it is needed for use by other cells. Eosinophils, thereby, resemble 
mast cells in having a significant function in extracellular metabolism. The peroxi­
dase-positive granules of neutrophils are not widely dispersed upon lysis of the 
cell and would probably function primarily in intracellular metabolism.
Eosinophils appear to have a direct relation to oxidative enzymes. Spitzers,
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1897, showed that the eosinophil granule is rich in iron and plays a significant 
part in the process of oxidation of iron-containing nucleoproteid (514). Winkler, 
1908, was the first investigator to recognize both oxidase and peroxidase in eosino­
phils and, with less activity, in other granulocytes. He also demonstrated a 
strongly oxidative reaction with eosinophils from gonorrheal pus (514).
Granules of eosinophil leukocytes give positive peroxidase reaction with a 
variety of staining methods (137, 253, 325, 349, 514, 580, 627). Agner (7) gives 
an extensive review of the literature on the presence of peroxidase in leukocytes, 
the discovery of the "peroxidatic" reaction by Klebs, 1868, and Strive, 1872, and 
the reaction of granules in leukocytes to form indophenol blue from a mixture of 
a-napthol and the Nadi reagent. Another school of investigators (319) warns 
that the so-called "oxidase reaction" obtained by use of alpha napthol demon­
strates a "special affinity of granules in leukocytes to napthol", but is mislead­
ing, for it "does not indicate the presence of oxidase nor . . .  of lipid" and is 
merely a napthol reaction. Woodward (631) points out that many authors doubt 
the occurrence of peroxidase in animal tissues. Weinkler, 1907, found Nadi- 
positive granules in the cytoplasm of myeloid cells, but not in lymphocytes (7). 
Agner (7) determined that this Nadi reaction was due to a peroxidase by extract­
ing verdoperoxidase from "leukocytes" in empyemic fluid. He found that the 
verdoperoxidase content of the "leukocytes" represented 1 to 2 per cent of the 
dry weight, which is 6 times the yield of peroxidase reported for the richest part 
of horse-radish root (7).
Brandenburg, 1900, using guiac resin-blue stain, found that bone marrow, 
pus, and leukemic blood gave a positive reaction for an iron and phosphorus- 
containing enzyme but that the thymus, lymph nodes, and spleen were negative 
(6). Agner's (6) review includes an excellent summary of opinions on whether 
the reaction is due to an oxidase or to peroxidase, and he concludes from the 
formation of indophenol blue, which can be provoked by peroxidatic reactions, 
that it is evident that the Nadi-reaction in leukocytes is conditioned by verdo­
peroxidase and that the verdoperoxidase occurs only in myeloid cells. Maehly 
(359) believes that myeloperoxidase, which is now considered about the same as 
verdoperoxidase (563), occurs in all myelogenic leukocytes but especially in 
granules of eosinophils.
Eosinophils have large, heavy granules when stained by Sato and Sekiya's 
method (137, 224), and younger myelocytes have fewer granules than later 
stages (224). Diggs, Sturm, and Bell (137) state that both eosinophils and neutro­
phils give a strongly positive reaction by Sato and Sekiya's method, but that 
eosinophils are laked, and the granules of basophils differ in their reaction from 
that of other methods. Carvalho, 1949, found that a modification of the peroxi­
dase reaction stained granules of eosinophils specifically (46).
Granules of eosinophils are also peroxidase-positive when stained by Graham's
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method and are large and closely packed in the cytoplasm as are the granules of 
eosinophils stained with eosin by Wright's method, thereby indicating that the 
peroxidase is present in the granules rather than in the cytoplasm. Eosinophils 
have deeply staining, round, glistening granules when stained by Moschkowski's 
method for peroxidase, in contrast with the staining of the cytoplasm in neutro­
phils which appears as a "compact brown mass" due to density of reaction (342). 
The peroxidase reaction of isolated granules has been investigated by only a few 
hematologists. The general principle involved in isolating the peroxidase granules 
is first to isolate and lyse the eosinophils; then the granules are separated by 
differential centrifugation in various media (39, 176). However, in studies on 
isolated granules it also is necessary to consider that the enzyme may be adsorbed 
to the surface of the granule, that the positive reaction represents a diffusion, 
or that the enzyme may be limited to either the outer or inner region of the granule.
P ero x id a se  in  C ells
Neutrophils, myelocytes, myeloblasts and endothelial leukocytes, as well as 
eosinophils, give the peroxidase reaction with Goodpastur's staining method (580). 
Peroxidase granules in neutrophils are decreased whenever toxic granulation is 
present (627). Basophils are also considered to be peroxidase positive (253). The 
cytoplasm of neutrophils contains large quantities of glycogen (46) and is not 
filled with large peroxidase-positive granules. The peroxidase in neutrophils 
appears to be free throughout the cytoplasm, in contrast with the localization of 
peroxidase within the granules of eosinophils. Neutrophils, which have a greater 
ability to ingest particles than eosinophils (46), can digest microorganisms and 
foreign particles of small size, because, as shown by Rebuck, 1947, Feissinger, 
1923, and others, the cell contains many enzymes such as proteolytic types, 
lipases, nucleotidase, and phosphatase (46). Eosinophils which have a very limited, 
if any significant, phagocytic functions, are mobile and motile and are adapted 
to conveying peroxidase granules to a given site where, following cytolysis, the 
peroxidase-bearing granules are scattered so that each granule becomes a peroxi- 
dase-distributing center. Other differences in the function of eosinophils and 
neutrophils have been mentioned. For example, certain eosinophils of turtles 
do not react to injections of turpentine and nucleic acid as do the heterophils 
(496).
The presence of peroxidase in monocytes has not been established, and Kracke 
(326) states that there is no agreement on the reaction of monocytes to peroxidase 
staining, but he (326) holds that those monocytes with visible granulation are 
peroxidase-positive. Kracke (326) also points out that the myeloblast is negative 
following Sato and Sekiya's stain for peroxidase.
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P ero x id a ses  in  A nimals
Several peroxidases are found in mammals and other vertebrates: myeloperoxi­
dase, now considered to include verdoperoxidase (563), lactoperoxidase, and 
salivary peroxidase. The leucocytes that contain myeloperoxidase (563) may also 
be the source of lactoperoxidase, which can form the same enzyme-substrate 
compounds as myeloperoxidase, and might be formed from peroxidase granules 
released from neutrophils and eosinophils. Eosinophils and neutrophils occur in 
interstitial tissue of the mammary gland (372, 374). Lactoperoxidase can oxidize 
tyrosine and differs in this function from horse-radish peroxidase (446).
D istribu tio n  of E osinophils
Eosinophils occur and have a wide distribution in the body fluids and organs 
of all vertebrates with the exception of certain fishes (481). A thorough review of 
the early literature on eosinophils was given by Schwarz in 1914. Opie (417) gives 
an excellent review of the literature on the origin and distribution of eosinophils 
in various tissues of higher vertebrates and the relation of these cells to nutrition. 
Ringoen (481) gives a thorough review on the phylogeny and morphology of 
eosinophils and their granules. Speirs (551) reviews the more recent literature on 
eosinophils and includes consideration of their relation to antigen-antibody reac­
tions and to hypersensitivity.
Eosinophils may occur normally, as tissue eosinophils, in the loose connective 
tissue of structures under conditions similar to the occurrence of mast cells (43, 
373, 597). The widespread distribution of eosinophils in the blood and other 
body fluids and tissues places these cells in the class with mast cells and other 
"free connective tissue cells" (371). Thus, these cells normally occur in the tissue 
fluid in loose connective tissue in the human mammary gland, lungs, and omen­
tum and are numerous in the areolar connective tissue of the guinea pig, mouse, 
and rat and always occur in greater numbers than the other granular leukocytes 
in the lamina propria of the small intestine (373) and form constituent elements 
of the mucosal stroma throughout the gastrointestinal tract (481). Other investi­
gators report that these cells are present in bone marrow and lymphoid tissue, 
especially in the thymus, lymph nodes, and spleen, and that they are found 
occasionally in the omentum and lungs (481). Eosinophils are abundant in lac- 
tating mammary glands (481), in the stroma of the mammary gland in guinea 
pigs, and also in the interlobular tissue of mammary gland of lactating rats (353). 
This cell also occurs in connective tissue of the human breast and may occur in 
the submucous connective tissue of the gastroenteral and respiratory tracts 
(181, 481). However, DaFano (125) states that he has never found true eosino­
phils in normal connective tissue of the mouse, while Fawcett (181) states that
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eosinophils are not nearly as numerous in the subcutaneous tissue of man as in 
this site in the rat, where these cells are 25 times as numerous as in the circulating 
blood of this mammal.
Eosinophils are numerous in peritoneal fluid (42, 225, 427, 481) and in the 
omentum (481) and occur in the loose subpannicular connective tissue on the 
back of the rat in the ratio of 2 eosinophils to 3 mast cells (42). Large numbers of 
eosinophils occur in the peritoneal fluid of both normal and tumor-bearing ham­
sters (305). The fact that eosinophils occur in loose connective tissues suggests 
that tissue eosinophils may arise by transformation of undifferentiated mesen­
chymal cells, but Maximow and Bloom (373) hold that most of the tissue eosino­
phils are eosinophil leukocytes which have emigrated from blood vessels and 
become established in the connective tissue, the exception being those in the 
connective tissue of the mucosa of the intestine, "where special conditions pre­
vail". Ewing (178) holds that physiologically eosinophils "are celomic tissue cells, 
finding their natural habitat in the tissues and not in the blood." It is necessary 
in evaluating numbers and distribution of eosinophils in tissues to recognize the 
fact that the usual fixation and staining methods used for tissues routinely im­
bedded in paraffin do not usually permit identification of these cells. In addition, 
some cells that stain with eosin may be other types, such as histiocytes (46), 
eosinophilized epithelial cells (578), Russell bodies or Charcot-Leyden crystals 
(481). The two forms of lactoperoxidase have been described, Lactoperoxidases 
A and B, which differ in reactions with dopa, spectrophotometric constants, and 
electrophoretic mobility (466). Perhaps these differences are due to difference in 
percentages of peroxidase derived from leukocytes and bacteria.
Verdoperoxidase, which occurs in a very high concentration in empyemic 
fluid from tuberculous patients (7) and in chloroma, also comes from leukocytes 
(511). Neutrophils contain as much as 2 per cent by weight of verdoperoxidase 
(584). Agner (6, 7) in his excellent reviews on the early literature on verdoperoxi­
dase in leukocytes mentions that one important function ascribed to this enzyme 
is the detoxication of bacterial toxins (359). Verdoperoxidase, which is now held 
to be the same as myeloperoxidase (563), is considered by Agner (7) to be a 
slightly modified form of peroxidase and to react less vigorously as a peroxidase.
Leucocytes are also considered a source of peroxidase in saliva. Nickerson, 
Kraus, and Perry (412) found that polymorphonuclear cells, chiefly neutrophils, 
accounted for the peroxidase positive cells in saliva sediment, and that peroxidase 
could not be demonstrated in the streptococci in saliva. These authors also main­
tain that the serous acinar cells are a rich source of peroxidase. Peroxidase has 
been reported by Dempsey, 1944, as being a normal component of thyroid cells 
and having a possible function in the formation of thyroxin (86); however, Glock 
attributes the effect to hemoglobin (631). The cytochrome system is considered
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the source of oxidative energy for synthesis of the thyroid hormone by 
Schachner, Franklin, and Chaikoff, 1943 (86).
I ron in  G ra n u les
The presence of iron in granules of eosinophils substantiates the occurrence of 
peroxidase because peroxidase is one of the iron oxidases found in mammals. 
However, literature on the amount of iron and the form in which it occurs in 
granules of eosinophils is controversial. Eosinophilic granules have been con­
sidered to be formed from hemoglobin or products of its breakdown (326, 480); 
Stachastnyi, 1905, and others hold that eosinophilic granules are derived from 
the products of degenerating erythrocytes (481). Barker reported that granules 
of the horse are 11 per cent iron (326), compared with hemoglobin, which con­
tains about 0.34 per cent (41, 616). Wislocki and co-workers (628) found that 
human eosinophils "contain no iron stainable by the Turnbull blue method"; 
but Barker, 1894, reported iron in human granules (481). Petry, 1908, mentioned 
that eosinophil granules have a function in iron metabolism (481) and that granules 
in the horse have a high iron content (83). Eosinophils have also been considered 
phagocytes (37, 481) of hemoglobin or products of its breakdown, which sub­
stances form the eosinophilic granules in the cytoplasm (326).
Cytochrome c oxidase, which is also an iron-porphyrin-protein, has been re­
ported in eosinophils. The amount of the total iron in peroxidase, therefore, 
cannot be readily distinguished from the amount in cytochrome c oxidase. The 
finding of large quantities of cytochrome in eosinophils convinced Amano that 
these cells probably transport or store cytochrome (602). Whether the cytochrome 
c oxidase in eosinophils is limited to the mitochondria of the cytoplasm, or pos­
sibly to mitochondria within or to other parts of the granules (10), has not been 
determined.
Cytochrome c oxidase has been reported in the granules of eosinophils (10, 622). 
It has not been determined whether this enzyme has functions which are limited 
to the development of granules, or whether it is present in sufficient quantities 
in granules of matured eosinophils and has a function in extracellular metabolism. 
Cytochrome c is associated with succinoxidase and cytochrome oxidase systems 
(264). The chief localization of cytochrome oxidase in mammals is in mitochondria 
(376), and the entire succinoxidase system is also practically exclusively localized 
in mitochondria (425). Use of labeled cytochrome c has shown that the cyto­
chromes in nuclear and microsomal fractions were adsorption but that only 10 
per cent of the cytochromes found in mitochondrial fractions was due to adsorp­
tion (40). If cytochrome oxidase is a significant product in granules, the eosino­
phils may have a function of readily stimulating erythropoiesis by releasing 
granules that increase the cytochrome oxidase activity after stimulation of hema-
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topoiesis induced by such stimuli as low oxygen tension, hemorrhage, and feeding 
cobalt (512). Cowdry, 1914, reported numerous mitochondria in some eosinophils 
and none in others (480), and at least 3 investigators have reported structures 
resembling cristae of mitochondria in some granules of eosinophils (437); however, 
Pease (437) does not believe that granules in the earliest myelocytes contain 
mitochondrial structures or that the eosinophil granules develop from mito­
chondria.
The function of eosinophils would not appear to be the storage and transpor­
tation of iron per se because iron is present in hemoglobin and myoglobin and 
also occurs in various combinations with certain plasma proteins (109). When 
large amounts of hematin form from disintegration of hemoglobin, portions of the 
hematin combine with albumin (247). Protoheme, the pigment of myoglobin 
(247), is present in muscles, while ferritin is the form once held to be stored in the 
reticulo-endothelial organs (639).
The protein to which the iron protoporphyrin is attached determines the method 
of functioning in biological oxidations (203). Peroxidases and catalases differ 
significantly from hemoglobin and cytochrome. Blood and muscle hemoglobin 
reversibly combine with oxygen in the ferrous state without being oxidized to the 
ferric state, and the cytochromes catalyze processes by undergoing rapid oxidation 
and reduction between ferrous and ferric states (204), whereas peroxidases and 
catalases are now considered to have a more complicated oxidation process than 
electron transfer and to function by undergoing higher oxidation states. The higher 
oxidation states, represented by FeJor, F e ^  , and Fe,™ , are considered to be 
due to oxidation of the iron atom itself or to electron or hydrogen atom abstrac­
tion from the porphyrin ring system (203).
The origin of peroxidase-containing cells from cells in the bone marrow is 
significant in view of the concentration of protohematin and hematin synthesis in 
hematopoietic tissue. Disintegration of erythrocytes in the bone marrow or spleen 
might be important as a source of hematin for synthesis of peroxidase. Eosinophil 
granulocytes, as well as neutrophils and platelets, normally develop in the bone 
marrow (283, 342) in adult mammals.
L ipid s
Lipids have been reported in the granules of eosinophils by a number of investi­
gators. Wislocki and co-workers (628, 629, 630) concluded that the granules of 
eosinop h ils  are lipoidal since they stained deeply and uniformly with sudan black 
B. Fawcett (182) also reports that these granules stain intensely with sudan black 
due to a coating of lipid, and Sehrt found that they stained readily with Sudan III 
(629). Bacsich (26) used Sudan III for staining lipoid granules in leukocytes, and 
Sheehan (527) used sudan black in 70% alcohol. Discombe (138) states that
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granules of eosinophils, as well as those of neutrophils, may be lipoid. However, 
Lillie and Burtner (349) attribute sudanophilia of leukocytes to a possible chemical 
combination of the dyes instead of true stain of lipids; in addition, they con­
cluded that the oxidase reactions were not due to presence of fatty acid peroxides. 
Baillif and Kimbrough (28) report that the shell of the granules of eosinophils 
stains with sudan black, whereas the core does not. Sections under the electron 
microscope show that granules of eosinophils may comprise two separate pieces 
with a lumen like the core of an apple (518). Vercauteren, 1951, in a study of 
isolated granules, demonstrated that the surface layers are composed of phos­
pholipids and that protein is present in the interior of the granule (46). The baso­
phil is considered by some hematologists to be an abnormal eosinophil which 
failed to mature because the younger forms of eosinophils sometimes contain 
basophilic granules (83).
Oth er  S ubstan ces in  G ra n u les
Eosinophilic granules have been reported to contain numerous substances, such 
as arginine, choline, nucleic acids, organic bound phosphate, and pentoses (605). 
Petry, 1908, found that these granules in the mouse contain 11 per cent iron, give 
xanthoproteic, oxidase, and peroxidase reactions, are soluble in concentrated alkali 
and in warm acetic acid, that neither trypsin or autolytic enzymes would digest 
the granules and that these granules do not give a fat reaction (481). Polysac­
charides are probably present in tissue eosinophils in the mucosa of the human 
appendix since both the granules and the cytoplasm gave a positive periodic acid- 
Schiff (PAS) reaction (630). Erankd (167) was unable to stain the granules with 
PAS, but the cytoplasm took the stain.
H istam in e
Eosinophils are often considered a source of histamine (604) because a definite 
increase in their number occurs in conditions of parasitism and foreign protein 
reactions. However, no definite correlation has been established between the 
blood histamine level and the number of blood eosinophils (107). Usually, eosino- 
phile counts and histamine levels are concomitantly high, but an increased number 
of eosinophils may be present with a normal level of histamine in the blood (107). 
Certain authors hypothesized that the eosinophils play an important part in the 
detoxication of histamine, and Vercauteren designated an antihistaminic sub­
stance obtained from isolated eosinophil granules 'antihistiminicum' (350). 
Lindahl (350) reports that an antihistaminic substance was obtained from eosino­
phils by Vercauteren's procedure. The active antihistaminic effect of this sub­
stance was thought to be due to the presence of phospholipids. Other investigators 
also hold that eosinophilia is a defense mechanism and that the chief function of
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the eosinophil is to combat formation of excess histamine (604), while Janeway 
(283) states that eosinophils remain a mystery and "their function is unknown".
The fact that histamine occurs in practically all tissues in mammals (41, 107, 
245, 252, 597) indicates the probable validity of the claims that this substance 
occurs in eosinophils (226, 325) at least in physiological traces. Indeed, some 
investigators (226) claim that normal eosinophils contain about 160 mg of hista­
mine to 109 cells and that one third of the histamine content of all the blood ele­
ments in chronic myelocytic leukemia is within the eosinophils. Code (107) states 
that it is questionable whether eosinophils ever carry appreciable quantities of 
histamine. Kovacs, 1950, holds that instead of releasing histamine, as was origi­
nally thought, eosinophils "do not contain histamine, but perhaps histaminase" 
(283). Code (107) points out the importance of checking the potassium content of 
extracts to avoid mistakenly attributing the similarity of the potassium response 
for that of histamine.
Several pathological conditions indicate that eosinophils do not contain hista­
mine. A fall in histamine content follows an influx of eosinophils into a tissue which 
has a high mast cell and a high histamine content (474). A bovine eosinophilic 
granuloma contained very little histamine (474), whereas an extremely high hista­
mine content (1290 ng/g) has been found in a mastocytoma of a dog (617). Eckert 
and Totterman (155), after making a series of observations on patients "with 
severe eosinophilia, both relative and absolute", concluded that all the evidence 
obtained contradicts the possibility of histamine being essential in eosinophils. 
Vaughn (604) suggests that eosinophils transport histamine or a similar toxic 
substance "from the bone marrow to the tissues for inactivation" and that the 
clinical syndrome known as eosinophilic infiltration of the lungs may possibly be 
explained by this concept. Rogers (159) states that eosinophils have been sug­
gested as the cells which manufacture or carry histamine and in this capacity 
probably initiate sloughing of skin homografts in man. He strongly favors "the 
hypothesis that eosinophilia is telltale evidence of an 'ill-defined allergic response' 
taking place in the tissues".
F unctions of P ero xid ase
The precise biochemical function of peroxidase has not been established, but 
this enzyme is known to use peroxide to oxidize many inorganic and organic sub­
stances (204). Peroxidase catalyzes oxidation of many phenols and aromatic amines 
in presence of peroxides (41). Peroxidase systems catalyze oxidation of oxaloace- 
tate, keto-malonate, and dihydroxytartrate (309). In the presence of a number of 
HaCVproducing enzyme systems, such as xanthine oxidase or D-amino-acid 
oxidase, peroxidase can oxidize manganese4-1- and, thus, in the presence of oxalic 
acid in either orthophosphate media, involve a cycle of oxidation and reduction
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(308). In the presence of hydrogen peroxide, peroxidase catalyzes the oxidation 
of ascorbic acid, epinephrine, tyrosine, many diamines, such as O-phenylenedia- 
mine; phenolic substances, such as guaiacum; aromatic monoamines, such as 
aniline; and indicators, such as phenolphthalein (370). The method and products 
of oxidized phenols remain obscure (624); phenols are also converted into aryl- 
sulphuric acid and arylglucuronides. Oxidation products of many phenols oxidize 
ascorbic acid (96).
Leukopenia and secondary pernicious anemia, occurring when linoleic acid 
is present in the diet of rats, have been attributed to oxidative breakdown of un­
saturated fatty acid (232). Tappel (576) states that the hematin catalyzed oxi­
dation of unsaturated fatty acids may occur in many types of oxidation of un­
saturated fats in vivo under pathological conditions, with formation of H2O2 
as a probable causative factor (232). Linoleic acid is oxidized by isolated mito­
chondria from rat liver, and it is also known that the unsaturated fatty acids are 
oxidized by the same mechanism as the saturated fatty acids (307). Tappel (575) 
states that the postulated mechanism of lineolate oxidation initiation involves 
a dual reaction of lineolate peroxide with hematin catalysts, and that hematin 
compounds appear to be very general peroxidative catalysts with a low order of 
specificity relative to the structure of the peroxide group or the molecule of which 
it is a part.
The functions of peroxidase and catalase differ in several ways from that of 
other iron oxidases. Cytochrome oxidase can catalyze oxidation of organic sub­
strates by molecular oxygen, but peroxidase and catalase cannot (247). Peroxi­
dases differ in function from hemoglobin and myoglobin in that peroxidase, as 
well as catalase, appears to form higher oxidation states, whereas the ferrous 
state of the hemoglobins combines reversibly with oxygen (203).
Peroxidase can act on extremely low concentrations of H2O2 (161), but the 
presence of hydrogen peroxide in living matter is considered doubtful (161). The 
presence of peroxidase in leukocytes and platelets and the controlled hormonal 
release of these granules from eosinophils might have a function in catalysing 
oxidations in extracellular fluids, whereas catalase, which occurs in all cells, is 
held to destroy H20 2 formed intracellularly. Peroxidase in dispersed granules of 
lysed eosinophils would appear to have a supplementary, extracellular function 
in those tissue fluids in which H20 2 is formed by extracellular metabolism of 
aerobic dehydrogenases in normal or in pathological conditions.
Peroxidases appear to be especially important in conditions in which there is 
catabolism of amino acids and purines, because several of the aerobic dehydrogen­
ases produce H20 2, which may in turn combine with peroxidase to oxidize other 
compounds produced during, or as a result of, protein catabolism. This process 
has been recognized in studies on tryptophane oxidase, which oxidizes trypto-
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phane to formylkynureinine (563) by using H20 2 formed by xanthine oxidase. 
It is possible that lactoperoxidase may also use H2O2 produced in reactions cata­
lyzed by xanthine oxidase, an enzyme that occurs in milk (563).
Hydrogen peroxide is formed in reactions catalyzed by several aerobic de­
hydrogenases, which function in catabolism of purines and amino acids. Xanthine 
oxidase dehydrogenates hydrated forms of hypoxanthine to xanthine and xanthine 
to uric acid (563, 592, 616). Uricase, in the presence of O2, converts uric acid to 
allantoin with formation of H2O2 (563, 592), in most mammals but not in snails, 
Dalmatian dogs, and primates (616). D-amino acid oxidase and L-amino acid 
oxidase function in the oxidative deamination of amino acids. Of these enzymes 
L-amino acid oxidase is the more important physiologically for it deaminates 
dietary, or L-amino, acids (245), while D-amino acid oxidase acts on unnatural, 
or D-amino, acids (616). Monamine oxidase (tyramine oxidase) deaminates 
primary amines forming aldehydes, ammonia, and hydrogen peroxide (563, 
616). Diamine oxidase in the presence of gaseous oxygen catalyzes the oxidation 
of "substances containing two or more —  NH2 groups, with the conversion of 
the— CH2NH2 group into — CHO" (335). Diamine oxidase is also believed to 
act 011 other substances, such as histamine (335).
The distribution of aerobic dehydrogenases (592) that produce H20 2 during 
steps of protein catabolism is important in considering significance of peroxidase 
in leukocytes. Xanthine oxidase occurs in the liver of man, in milk, in several 
organs in the ox, and in rat blood (563); but it is absent from the liver of the 
hedgehog and dog (616). D-amino acid oxidase is present in most animal organs, 
especially the kidneys and liver (335, 563). L-amino-oxidase is also present in 
the liver and kidney (245); however, uricase is present in the liver, spleen, and 
kidney of most mammals but is absent in the liver of primates and the Dalmatian 
dog (616). Mono-amine oxidase occurs in the liver, and in the kidney, intestine, 
brain, placenta, and lung in vertebrates and is also found in invertebrates (563), 
whereas diamine oxidase has widespread distribution (563). Histidase, in higher 
animals, occurs only in the liver (563).
The liver is an organ in which most of the aerobic dehydrogenases produce 
H2O2 (245). The concentration and retention of peroxidase in the spleen becomes 
especially significant. Myeloperoxidase, which has a concentration of about 
1.0 per cent in leukocytes (563), is abundant in the spleen (41). Leukocytes, which 
are retained in splenic sinusoids, contain peroxidase-positive granules, as indi­
cated in imprints of the spleen of hamsters stained by Graham's peroxidase 
method (305). The liver is in direct contact with the spleen via the portal vein 
and receives a much higher concentration of peroxidase than most other organs, 
except the bone marrow, where the peroxidase-containing cells are formed.
Peroxidase occurs in eosinophils, neutrophils, and platelets, but it does not
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occur in other cells, whereas catalase is present in all cells. The function of peroxi­
dase in granules of eosinophils would, therefore, probably be related to catalysis 
of peroxidatic reactions in intercellular tissue fluids or other body fluids.
Peroxidase and Catalase
Peroxidase granules in eosinophils and neutrophils might supplement or re­
place some of the peroxidatic reactions of catalase. For example, castration in 
young adult male mice or adrenalectomy decreases activity of catalase, while 
testosterone injected into females increased the level to that of males (3). The 
function usually ascribed to catalase is decomposition of hydrogen peroxide; 
for example, one molecule of catalase has been considered capable of decom­
posing 2,640,000 (41) to 5,000,000 (335) molecules of H20 2 at 0° C.
Catalase, present in all cells, including hepatic cells (616), has been credited 
with having several oxidative and peroxidative functions. McClendon (376) 
states that "catalase is probably a peroxidase in vivo". Coupled oxidation, rather 
than decomposition, of the H20 2 has been considered a significant function of 
catalase (297) in all cells. Catalase in liver cells is present in 1000 times the amount 
necessary for decomposition of the usual content of H20 2. Catalase, in the pres­
ence of H20 2 oxidizes ethanol to acetaldehyde (11). Ribose-5-phosphate is oxi­
dized by catalase in a system that slowly generates H20 2, such as glucose, glucose- 
oxidase (191). Catalase in the presence of H20 2 can also peroxidatively oxidize 
alcohols (36, 95, 96).
Catalase from the liver can act as a peroxidase to couple various substances 
such as epinephrine or tyrosine with catechol, but peroxidase can not act as a 
catalase to decompose H20 2 without a second substrate (577). Although the 
main function of catalase is considered the protection of cells from toxic effect 
and H20 2 (297), such as protection of the oxidation system from excessive H20 2 
produced by enzymes that convert L-tryptophan to kynurenine (318), catalase 
from the liver may have other functions, such as a role in bile pigment formation, 
a process that has been demonstrated in vitro (306).
Greater resistance to some inhibitors may indicate that peroxidase can replace 
catalase under conditions in which catalase is inhibited and peroxidase is not. 
Goldacre and Galston (216) reported 2,4-Dichlorophenol (DCP) did not inhibit 
peroxidase, cytochrome oxidase, or hemoglobin at a concentration of 2 X 10~6 
M, but that catalase was reversibly half-inhibited at this concentration. Lemberg 
and Legge (343) demonstrated that ascorbic acid causes inhibition of catalase 
by accelerating the destruction of the enzyme by H20 2 with production of bile 
pigment haemoprotein. Sulfanilamides and sulfapyridine also have an anticata- 
lase activity in man (106). Two of the four centers for attachment of enzyme 
inhibitors to catalase are acted upon by azide and cyanide groups and the re­
maining two by phenol and H+ (417). Inhibition, of catalase is also suggested 
as a possible cause of the formation of Heinz bodies in erythrocytes (74).
Increased or sporadic function of an organ or of pathological conditions may 
also require supplementation of peroxidases from leukocytes. Xanthine oxidase 
activity in the breast increases many times during pregnancy (346). The infiltra­
tions by eosinophils and neutrophils in the mammary gland during pregnancy 
and lactation may catalyze oxidations utilizing H2O2 produced by this enzyme 
(373). Absence of catalase in blood and liver, muscle and bone marrow has been 
reported (571), and is a condition which is considered to be due to a recessive 
gene (408).
Protein Catabolism
One concept of the function of the eosinophil is that this cell plays an important 
part in protein metabolism. Heidenhain in 1888 believed that eosinophils were 
more numerous in the intestinal mucosa of normal than of starved animals and 
that these cells play a part in nutrition. His view was upheld and amplified by 
several later investigators. Vaughn (604) states that Rous found that in dogs a 
meal rich in protein was followed by a much greater increase in eosinophils in 
the lymph than after a carbohydrate meal. Ringoen (481) cites several writers 
who hold that the most satisfactory explanation of eosinophilia rests on the basis 
of chemotaxis which is, in all probability, correlated with "a reaction against the 
toxic products of autogenous or parenteral foreign proteins". This idea is sup­
ported by Hajos and Mazgon's idea that "eosinophils function in desensitization" 
(481) and by Vercautern's (605) holding that eosinophilic granules play a part in 
detoxication of histamine.
The literature affords very little direct evidence as a basis for explaining the 
functions of eosinophils. Beattie and Dickson (37) incidentally indicate a nutritive 
function for these cells by stating that eosinophils "are fragile, and readily break 
down, with scattering of their granules", and Wintrobe (627) says that since 
"eosinophilia is characteristic of allergic disorders . . .  it is held that eosinophils 
are concerned in the disintegration and removal of protein". Liebman (348) 
ascribes to eosinophils a secretory function which is "connected with protoplasmic, 
probably protein, breakdown" in eggs of the salamander, Triturus viridescens; 
and he states that eosinophils are the only leukocytes found in these eggs after the 
neutrophils have disappeared.
The literature on changes in the numbers of eosinophils is often difficult to 
evaluate because many investigators are contented with blood levels, while others 
may include both tissue and blood values without distinction in discussing results 
obtained. Most of the explanations of the cause of tissue (local and/or blood) 
eosinophilia involve hormonal, toxic, or other effects of necrosis (37, 407, 470), or
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foreign protein reactions, including anaphalactic, histaminic, hypersensitive or 
allergic, inflammatory, and other reactions (37, 159, 240, 315, 377, 549). Rogers, 
1953, (159) strongly favors the idea that eosinophilia is strong evidence of an 
" 'ill-defined allergic response' "  in the tissues, and suggests that this cell "carries 
or manufactures histamine" (159).
L ymphopenia
One important condition in which protein catabolism is increased is the lysis 
of large numbers of small lymphocytes. Many normal and pathological conditions 
cause concomitant changes in lymphocytes and eosinophils; however, the signifi­
cance of the parallel effects has not been determined. It is possible that the rapid 
and extensive lysis of lymphocytes increases the formation of hydrogen peroxide 
by the aerobic dehydrogenases which act on purines and amino acids and that 
a factor produced during protein catabolism causes lysis of eosinophils; however, 
the same, as yet unknown, mechanism that causes the lysis of small lymphocytes 
may also cause eosinophils to disrupt and release their granules.
The dependence of eosinophilia on protein degradation is shown by the effects 
of fasting (214, 277), ACTH, and/or cortisone (116, 133, 255, 328, 390, 421, 552); 
gestation and/or parturition in hamsters (301), in several stocks of mice (234), 
and in women (332).
A high carbohydrate diet decreases, while a high protein diet increases eosino­
phils. When fasted dogs were realimentated with an isocaloric protein diet, 
both capillary resistance and number of eosinophils rapidly returned to normal. 
Increasing the protein to a high level hastened the return to normalcy, while a 
diet high in carbohydrate tended to stabilize capillary permeability and eosino­
phils at the fasting levels (623). Apparently protein as such was not responsible 
for the increase in eosinophils, for Vartiainen and Apajalahti (603) found during 
6 hours after feeding proteins to 24 healthy test subjects that casein (0.5 g/kg 
body weight) and tyrosine (0.6 g/kg) produced a fall of 33 and 86 per cent, re­
spectively, 4 hours after ingestion, while gelatin (0.5 g/kg) had no effect on blood 
eosinophil counts. It has been shown that the eosinophil and lymphocyte counts 
fall in fasting dogs, but rapidly return to normal upon realimentation with high 
protein but not with high carbohydrate diet (623). Feeding quantities of liver, 
especially raw calf's liver, increased eosinophils 10 to 74 per cent (480).
A number of observers hold that since eosinophils are credited with playing a 
part in the "disintegration and removal of protein" (627) the presence of foreign 
or abnormal protein, such as products of destruction of lymphocytes which Bunt­
ing (83) holds are "specifically chemotactic for eosinophils", induces eosinophilia.
Protein leakage, one of several changes in allergical reactions, is considered to 
occur before infiltration of eosinophils (597). This tenet is supported by numerous
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observations which indicate that many, if not all, antiphlogistic agents, such as 
cortisone and ACTH (520), which cause conditions of increased capillary permea­
bility to return to normalcy, reduce the accompanying eosinophilia.
The fact that eosinophils are not present in unusual numbers at the site of 
allergic reaction until after hyperemia and consequent protein leakage have 
appeared (597, 604) indicates that the function of the eosinophil is to combat, 
rather than cause, the allergic reactions (107, 325, 597, 604, 627). Most observers 
state that they believe eosinophilia is characteristic of, or related to, allergic 
disorders (37). However, Vaughn (604) holds that the release of "histamine or 
some similar toxic substance . . .  in abnormal quantities" results in eosinophilia of 
the blood. He points out that histamine is released during antigen-antibody 
proteolysis, which is associated with "proteolysis by intracellular trypsins". 
Many pathological processes, such as post-febrile states, allergic states, cancer, 
round worm infestations, and many therapeutic reactions have sufficient degree of 
breakdown of foreign, normal, and abnormal protein in the tissues to "allow 
release of histamine to be postulated", which he thinks would account for the 
accompanying eosinophilia (604). Egg albumin, hemoglobin, erythrocyte sus­
pensions, and a mixture of hemoglobin and an erythrocyte suspension repeatedly 
injected produced a definite increase in blood eosinophils (480). Injection of 
peptone and protein caused local eosinophilia, but injection of amino acids had 
no effect (53).
Cortisone and ACTH
Cortisone is a strong eosinopenic and lymphocytopenic agent. Most agents 
that deplete lymphocytes and lymphoid tissue also deplete eosinophils (116). 
ACTH has been shown to deplete both eosinophils and lymphocytes (459) through 
its stimulation of the adrenal cortex to produce adrenal corticosteroids, chiefly 
cortisone (283), which has a lytic action on lymphocytes. Chronic cortisone treat­
ment definitely depleted the eosinophils, as well as the lymphocytes and lymphoid 
tissue, in hamsters (116, 305). Thus, it is not surprising that Kovacs, 1950, found 
that blood eosinophils are depleted by administration of adrenal corticosteroids 
or corticotropin (283).
Peritoneal eosinophils appear to be much less sensitive to the action of certain 
hormones than circulating eosinophils. Subcutaneous and intraperitoneal injec­
tions of cortisone, hydrocortisone, epinephrine, and histamine had little effect on 
the number of eosinophils in the peritoneum of mice previously pretreated with 
horse serum, but produced a marked peripheral blood eosinopenia within 3 hours 
(427). Speirs, 1952, found that administration of cortisone caused morphological 
changes with cytoplasmic budding and fragmentation of eosinophils in the peri­
toneum of rats, and these fragments were engulfed by free phagocytes (427).
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Ham (297) suggests that cortisone produces eosinopenia by causing these cells to 
leave the blood vascular system and, presumably, to invade the connective tissues, 
while Padawer and Gordon (420) state that throughout the period of the develop­
ing eosinopenia following injection of cortisone or epinephrine, the peripheral 
blood contains a marked increase in fragments of eosinophils. Kramar, et al. 
(328) hold that during cortisone increase (the first phase of stress response is 
presumably associated with ACTH discharge) capillary resistance rises and the 
eosinophil level falls in normal and adrenalectomized animals; at withdrawal of 
the cortisone the capillary resistance drops precipitously, and eosinophilia super­
venes.
A group of investigators report that irrespective of the kind of stress or agent 
used, including cortisone, 3 to 4 hours elapsed before a significant fall in eosinophils 
occurred in normal animals. Love obtained eosinopenia in adrenalectomized 
animals within 10 minutes after stress, which apparently was considered due to a 
non-cortisone, humoral agent (574). Keleman and co-workers (298) found that 
subcutaneous injection of 500-600 mg/kg of salicylates decreased the eosinophil 
number 10 to 30 per cent 4 hours later in rats, while others report that sodium 
salicylate inhibits inflammation in rats (601).
Little is definitely known about the mode of action of agents which destroy 
eosinophils in vivo. Apparently, the problem with regard to the action of cortical 
steroids is whether or not the substance acts directly or indirectly on the eosino­
phils. Some investigators point out the fact that cortical steroids are ineffective 
in vitro (574), but are effective in vivo, thereby indicating an indirect action 
(222, 574). Gordon (222) suggests that the results of work by Meuhrcke and 
co-workers in obtaining eosinopenia in defibrinated human blood in vitro by 
addition of cortisone and their finding that heparin apparently blocks this action 
of cortisone are evidence of a direct action of cortisone. However, Speirs circulated 
cortisone through preparations of the isolated liver and found that the steroids 
thus obtained had no effect on eosinophils either within the isolated system or 
within the animal (222).
Since many, if not all, agents which favor production of eosinopenia are anti- 
phlogistics, it may be in order to consider disturbance of glycolysis as a con­
tributing factor in eosinopenia. It has been shown that substances commonly 
used in treating rheumatism, such as acetylsalicylic acid, adrenocorticotropin 
(ACTH) monoiodoacetic acid, phlorizin, and salicylic acid, effectively inhibit 
reduction of triphenyltetrazolium chloride in isolated cornea. From these obser­
vations the investigators concluded that the antirheumatic and antiphlogistic 
effects of these substances are related to their disturbing glycolysis, which is 
important in development of inflammation, for 'forapin', a phlogistic substance, 
enhanced the activity of dehydrases in the cornea in situ (322).
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Stimulation of protein catabolism was considered one of the properties of 
"the cortical hormone" by Long, Katzin, and Fry in 1940. Since then, cortisone 
or ACTH has been found to increase protein catabolism (312, 436) to produce 
a negative nitrogen balance (275, 358, 482) and to increase purine in the urine 
(356). Not only does cortisone increase protein catabolism, but it is also believed 
to decrease protein anabolism. Cortisone has been reported by Skipper, 1951, 
to inhibit incorporation of labeled formate into RNA and DNA in the viscera of 
mice (270).
A greater negative nitrogen balance is caused by ACTH and cortisone than by 
salicylates in children having their second or third attacks of rheumatic fever. 
However, the serum amino acid-level was increased 2 to 18 hours after injection 
of 25 mg of cortisone into rabbits (146). Production of lymphopenia and depletion 
of lymphoid tissues has been considered a source of the protein catabolized by 
administration of cortisone or ACTH, and Needham (409) supports this idea by 
stating that lymphoid tissues may furnish the main, if not the entire, source of 
protein depleted by cortisone. Other investigators (321) have suggested that 
one specific function of ACTH is mobilization of protein from lymphoid tissue 
(321). The use of adrenal cortical substance has been considered a sensitive method 
for mobilization of protein from lymphoid tissue (202). Carbohydrate administra­
tion does not modify the mobilization of protein from lymphoid tissue after 
treatment with ACTH (166). The mechanism by which cortisone and ACTH 
effect lymphoid depletion has not been determined. Engel (166) asks "Why do 
certain tissues, such as lymphoid tissue, respond so much more actively in protein 
metabolism than others?"
E pinephrine
In order to evaluate effects of epinephrine, ACTH, or cortisone on the number 
of eosinophils in the blood, it is necessary to recognize the counterbalancing, or 
antagonistic, effects of histamine and epinephrine (238, 490) and the opposite 
effects of these two substances on eosinophils (490). Injection of histamine stimu­
lates release from the medulla of the adrenal of epinephrine (564), which reduces 
the number of eosinophils (215), but adrenalectomy in rats increases histamine 
content in the liver, lung, and gastrointestinal tract (573). Furthermore, ACTH, 
as well as cortisone, has an ameliorating effect on excessive histamine in allergical 
reactions (459, 460, 490). It is also necessary to consider that localization of 
eosinophils in several organs as well as increased lysis or decreased production of 
the cell (420) can cause eosinopenia. Since fluctuations in the level of circulating 
eosinophils may result from nonspecific stress, as well as from variations in normal 
adrenocortical function (215), precautions should be taken in evaluating the 
significance of changes in the eosinophil level following administration of these 
substances.
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Epinephrine reduces both eosinophils and lymphocytes and may cause an 
eosinopenia (215), which is not prevented by hypophysectomy and, thereby, 
not considered to be due to increased ACTH augmenting corticoid production 
(520). Glaser (212) states that occasionally epinephrine may induce eosinopenia; 
Broch and Haugen (76) hold that the effects of epinephrine on eosinophil counts 
are too variable to be used as a reliable clinical test. Tyler, 1950, points out that 
epinephrine injections produce a transitory peak increase of 50 to 300 per cent 
in eosinophils, as well as in lymphocytes and polymorphonuclears, in man within 
about 15 minutes which is missed in counts made an hour after injection (548). 
Epinephrine also decreased eosinophilia in allergical patients, and in mice and 
rats infected with Trichina spiralis when adrenals were present; however, epi­
nephrine did not cause eosinopenia in mice pretreated with ascorbic acid but did 
cause eosinopenia in mice pretreated with saline (24).
Serum from rats previously stressed for four hours by injection of epinephrine 
reduced the eosinophil count 50 per cent within 30 minutes after injection into 
normal rats (574). Injections of 50 jug of ACTH produced an average decrease of 
eosinophils of 87 per cent in mice previously stressed by injection of epinephrine. 
However, it is admitted that in normal mice mild stress of epinephrine injections 
produced a great decrease in the number of circulating eosinophils. A temporary 
rise in eosinophil count sets in after 7 hours of the stress-produced eosinopenia. 
The fact that injection of adrenal cortical hormones produced eosinopenia pro­
portional to the dosage supports Selye's (520) contention that "the effect of 
adrenaline upon the eosinophils is mediated by the adrenal cortex". It has also 
been suggested that epinephrine has a direct but less powerful effect on the adrenal 
cortex of man than ACTH (64) and that its effects are mediated through rapidly 
increased production of ACTH (573). Epinephrine is thereby considered by cer­
tain investigators to be a type of humoral regulator of ACTH release (212). 
However, epinephrine is also considered to have a direct effect on causing eosino­
penia as indicated by epinephrine causing eosinopenia in hypophysectomized 
animals (520), and this hormone alone may occasionally induce eosinopenia (212). 
Patients with hypopituitary activity are unable to secrete ACTH, and usually 
have a decreased eosinophil count following injections of epinephrine or conditions 
of stress (573). There is such close relationship between the eosinophil count and 
hypophysical and/or adrenocortical function that changes produced in the number 
of eosinophils following administration of either epinephrine or ACTH solution 
are the basis for tests to determine the presence of hypopituitaryism or hypo­
adrenocorticism. The procedures, with variations, for making the ACTH-Eosino- 
phil test and the Ephinephrine-Eosinophil test are described by Talbot, Sobel, 
McArthur, and Crawford (573), and have been adapted to use in pre- and post­
operative surgery by Roche, Hills, and Thorn (488).
Dispersion of the peroxidase-containing eosinophil granules may have a func­
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tion in inactivating epinephrine. Lysis of eosinophils is a source of increased 
peroxidase and catalase titer of the blood of rabbits reported by Vacca, one hour 
after an injection of adrenalin (522). In addition, contraction of the spleen caused 
by adrenalin (547) increases the number of eosinophils and neutrophils in the 
blood. Eosinopenia has been reported in splenectomized rats after injection of 
epinephrine, but changes in neutrophils or lymphocytes were not observed (520).
Peroxidase in the presence of H2O2 can oxidize epinephrine, and other amines 
(249). In vitro experiments have shown that the horseradish peroxidase-H^Oo 
system destroys the pressor action of epinephrine (254) and that epinephrine was 
oxidized, as was shown by Szent-Gyorgi (254). Leucocytes of a crab (Cancer 
pagurus) contain a phenolase, which is capable of catalyzing the oxidation of 
adrenalin; however, it was reported that active phenolases of this type were not 
found in animals of any other phylum and, further, that the enzymatic capability 
of many phenolases to oxidize epinephrine is doubtful since the cytochrome oxidase 
system can catalyse catechol derivatives (50). Martin (370) also states that in 
vivo oxidation of epinephrine by phenolases is uncertain.
There are numerous other means of inactivating adrenalin. Blaschko, Richter, 
and Schlossman (62) describe the activity of an enzyme, adrenaline oxidase, 
which occurs in the liver, kidney, and intestine. The cytochrome oxidase system 
can oxidize epinephrine (194) as can polyphenoloxidase. In addition, adrenalin 
is inactivated by conjugation, which is probably the chief physiological method 
used by the body (624). Blaschko and Schlossmann (62) state that polyphenol 
oxidase, cytochrome oxidase, or peroxides in a phosphate buffer at pH 7.3 can 
inactivate adrenalin and form a red substance that is probably adrenochrome.
F ever
Fever may also increase peroxidase activity by increasing protein catabolism. 
Pyrexia increases protein catabolism and thus increases utilization of proteins 
as well as carbohydrates and fats (37). Fever of 1°, which increases basal metabo­
lism 7 per cent, increases the amount of urea, ammonia, and nitrogenous bodies 
excreted and causes rapid utilization of carbohydrate in the liver and muscle, 
resulting in a state of inanition with increased metabolism of proteins and fats 
(90). The cause of the heat is considered to be accelerated oxidation. There is 
also loss of appetite with diminished food intake, impaired digestion, and exces­
sive catabolism. Tissue protein, especially that of the muscles, is rapidly catab- 
olized, and the nitrogen balance speedily becomes negative (607).
Great increases in extracellular oxidation outside the mitochondrial-cyto­
chrome system may be a cause of pyrexia or excess body temperature. For ex­
ample, the energy in oxidation of the tricarboxylic cycle to C02 and H20 2, which 
occurs in the mitochondrial-cytochrome system, is converted to the formation
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of ATP, and stores about 686,000 calories (616). Several groups of investigators 
(271) estimate that the passage of one pair of electrons forms 3 moles of ATP 
and that this figure represents conversion of 60-65 per cent of the energy of oxida­
tion to energy in the phosphate bond. Oxidations in fluids or cells where this 
conversion does not occur would not form ATP, and the energy would be re­
leased as heat. Mitochondria occur in granulocytes (46), and these cells might 
convert energy to ATP within the cytoplasm; however, extracellular oxidations, 
which occur in body fluids, probably would not convert energy to formation 
of high energy phosphate bonds. A systematic or extensive increase in extracel­
lular oxidation could, thereby, cause fever. There are other changes produced by 
fever which may affect the number of eosinophils (520).
Peroxidase from eosinophils and neutrophils, by infiltration and subsequent 
disintegration in exudates, may also have a function in protein catabolism. Re­
moval of injurious material by phagocytic cells has been attributed to the presence 
of proteolytic enzymes in these cells (387), and a greater amount of amino acids 
has been found in pleural fluid in inflamed conditions than occurred in the serum 
of the dog (387). Thus Menkin's (387) results confirm the observations of other 
investigators that "proteolysis is very active in exudates" and produces many 
split products.
Differences in protein catabolism, necrosis, and proteolysis, which occur at 
the margins and within the stroma of various tumors (305), may also be related 
to differences in extent of eosinophil infiltration. Eosinophils infiltrate certain 
uterine carcinomas in great numbers (586), mast cell tumors of the dog and horse 
and granulomas of the cat (450), neoplasms of the digestive tract (53, 481), and 
certain bone tumors (179). Kappis, 1907, reported blood eosinophilia of 33.6 
to 35.5 per cent and numerous eosinophils infiltrating necrotic areas of a carcinoma 
of the lung. Others report eosinophilia up to 48.28 per cent for patients with 
carcinoma of the neck, cervix uteri, colon (481), and other sites.
Whether the tumor stimulates blood eosinophilia or merely attracts these cells 
from the blood stream so that they infiltrate the tumor is still debated (481). 
Murray (407) suggests that, "the absolute eosinophil count may be a valuable 
test" to differentiate a malignant from an infectious process. Contrarily, Ringoen 
(481) states that "malignant tumors rarely produce eosinophilia" while Simon, 
1906, holds that "hypereosinophilia is probably more common in carcinoma of 
the uterus than in any other form of malignancy" (481).
S carlatina
Increased protein catabolism, which is caused by various factors, may be a 
factor in the very pronounced eosinophilia usually observed in scarlet fever. 
Protein catabolism is altered when there is an acute, diffuse glomerular nephritis,
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which develops in 84 per cent of the cases of scarlet fever (90). An increase in 
adrenergic substances, which also increases protein catabolism, has also been 
found in the blood of 17 of 26 cases. Hypersensitiveness, which has been con­
sidered the cause of arthritis due to tissues of the joints being sensitive to a toxic 
product, would also evoke an eosinophilic response. Another possible cause of 
eosinophilia may be the increased breakdown of amino acids released following 
increased activity of plasmin. Group A hemolytic streptococci produces an acti­
vator, streptokinase, for plasminogen, the inactive form of the active proteolytic 
enzyme, plasmin (453), an enzyme which lyses fibrinogen and fibrin (41).
Peroxidase may function in inactivation of the scarlet fever toxin as well as in 
catalyzing oxidations of purines and amino acids. Scarlet fever toxin is a protein 
which is stable to the action of trypsin and pepsin and contains amino groups 
essential for its toxicity (247). Reaction of eosinophils may be important in this 
relation because granules of eosinophils, which are not digested by tryptase 
(326), may furnish peroxidase to inactivate the toxin. The inactivation process 
may be similar to the one described by Pappenheimer, 1948, who holds that the 
toxin of diptheria is a globulin-like protein which combines readily with iron- 
porphyrins and that this combination may form a respiratory enzyme (247). 
Agner (8), after reviewing the literature, states that crude diphtheria toxins are 
detoxified by peroxidases in the presence of H20 2 ; however, under similar condi­
tions, purified toxin was not detoxified. Agner (8) noted that an intermediate 
product of oxidation of uric acid might react with diphtheria toxin to detoxify it. 
Hydrogen peroxide, a product of several steps in oxidation of uric acid (592), 
might be this intermediate agent. In addition, peroxidase in the presence of hy­
drogen peroxide inactivated Rh-antibodies in serum in vitro (610).
F oreign  P rotein  R eaction
Anaphylaxis is another condition in which eosinophilia (501) and a rapid in­
creased protein catabolism occur. Bronfenbrenner, 1944, considered that anaphy­
laxis was due to activation of serum tryptase (597). Bergmann and Fruton, 1941, 
found that the peptide linkages containing the carboxyl group of either arginine 
or lysine are acted upon by trypsin, while chymotrypsin acts on "peptide linkages 
involving the carboxyl group of tyrosine and phenylalanine" (249). Trypsin 
is considered to act more rapidly on the ester linkage — CO— OR than on the 
peptide linkage and requires — NH — CHR' — CO—  part of a molecule which 
must be derived from a diaminomonocarboxylic acids (arginine, lysine) or from 
norleucine and histidine (335). Cathepsin II, which is homospecific with trypsin 
(335), requires that basic sidechains of arginine and histidine for action (247).
Increased histamine increases extracellular protein catabolism through increas­
ing capillary permeability. The eosinophilia which occurs after the bite of the
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black widow spider (224, 326) has been related to histamine release since urticaria 
is one of the symptoms (378) but it may also be a response to direct or indirect 
effects on the six proteins of the venom (403) or to lytic effect of venom on plasma 
or other proteins. Eosinophilia is also caused by injecting the toxin of the flannel 
moth (Megalopyge urens Berg) into rabbits (375).
Mechanical stimulation of a lesion of urticaria pigmentosa incited eosinophilia 
(450). The release of histamine from greatly increased numbers of mast cells in 
the skin in urticaria pigmentosa may be the cause of eosinophilia observed in 
this condition and also the cause of eosinophilia in eosinophilic granulomas. 
An increase in histamine was reported by Macdonald in four cases of eosinophilia 
(458). Mast cells, which are abundant in eosinophilic granuloma (450), are con­
sidered an ideal condition for the development of marked tissue eosinophilia 
(450). Horseradish peroxidase in the presence of H20 2 partly destroys the irritat­
ing properties of poison ivy allergents (97). Peroxidase has also been considered to 
inactivate RH-antibodies (610).
P arasites
There are several direct and indirect causes of decomposition of protein in 
parasitic infestations. Thus, not only the parasite, but other effects of the infesta­
tion, such as hemorrhage, infiltration and necrosis of leukocytes, and fever in­
crease extracellular protein catabolism.
Eosinophilia occurs in the later stages in most parasitic infestations by intestinal 
worms, amebiasis, filariasis, and trichaniasis, especially after cyst-formation in 
the muscles (56), in infestations of the lung by mites of the genus Tyroglyphus 
(37), and by the larvae of Ascaris (324) which pass into pulmonary alveoli. Eo­
sinophilia in infestations may be as high as 80 per cent eosinophils of the total 
number of leukocytes and is also accompanied by an increase in the other white 
cells (224). In echinoccocus disease the eosinophils often reach 50 per cent of the 
white count, while in trichinosis they may reach an absolute count of 15,000 per 
mm3 and may represent as much as 85 per cent of the white count (627).
Protein decomposed by necrosis is probably one of the most important stimuli 
for the local tissue eosinophilia in some parasitic infestations around living micro­
filaria in the ciliary body, vitreous or optic nerve. Death of the parasites or of 
only a segment of a single worm, produces a granulomatous reaction which, in 
some cases, becomes necrotic, and eosinophils form compact masses around the 
dead part (324). Necrosis of the muscle around some parasites (4), such as trichina 
larvae, is a contributing factor for eosinophilic infiltrations.
Several other pathological changes produced by parasites alter protein metab­
olism. Formation of a lymph thrombus, induced by the adult worm or debris 
(in filiariasis) or disintegration of the parasite (324), produces edema, with eo-
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sinophils and other leukocytes infiltrating the focalized regions of edema and 
necrosis in the retina and in the lesions of infantile toxoplasmic retino-chloroiditis 
(320). Hemorrhage and leukocytic infiltrations also augment the foreign protein 
reaction in migration of Ascaris larvae into the lung, a process that causes fever, 
hemorrhages and broncho-pneumonic areas, and sometimes eosinophilia (625).
Increases in extracellular fluids are produced by parasites. The blister found 
in dracunuliasis is believed to appear when the Guinea worm's head reaches 
the epidermis (324). It is believed that an increased protein destruction is causally 
related to the profound systemic symptoms which precede the appearance of 
local hyperemia and small, red papules by some 24 hours, by the formation of 
the characteristic 2 to 7 cm blister beneath which the head of the worm lies, and 
through the small necrotic center of which the blister fluid containing serum, 
fluid excreted by the worm, lymphocytes, plasmacytes, and many eosinophils 
exudes. The subcutaneous, fibroblastic sheath in which the female worm lies 
is surrounded by a zone densely infiltrated with eosinophils, lymphocytes, and 
plasmacytes (324). The 4 to 5 cm Calabar, or fugitive, swellings which develop 
in the body skin during the course of loliasis, or infection by the loa loa, or 'eye 
worm', is usually accompanied by "a high peripheral eosinophilia" (324). The 
death of an eye worm (in loaiasis) causes abscess formations infected by bacteria, 
a condition that further augments extracellular protein catabolism (324).
A high local and/or peripheral eosinophilia apparently is characteristic of 
infestation by worms, especially round worms, and is generally conceded to be a 
response to putrefactive processes occasioned by death of the worm, to fluid 
excreted by the parasites, and/or the allergic or necrotic reaction caused in the 
surrounding tissues. Oxidation changes might also be a causative factor for eo­
sinophilic changes in several parasitic infestations. For example, Wharton (618) 
reports on the occurrence and relations of hemoglobin in several worms in the 
turtle. He shows that certain parasites living free in the blood stream, such as 
Cruzia testudinis and Falcaustra affinis, lack hemoglobin, while others which 
merely have contact with the blood stream, such as Allassostoma magnum, 
Camallanus trispinosus and Telorchis robustus, have Hb, which has a greater 
affinity for oxygen than that of the host. If eosinophils have a function in furnish­
ing peroxidase, the granules may function in catalyzing peroxidatic reactions 
of the parasite, as well as of the host; for example, H20 2 produced by diamino 
acid oxidase may be used in the presence of peroxidase to oxidize a substrate of 
the parasite.
Eosinophilia in infiltration by Ascaris and other parasites has been attributed 
to a hypersensitive response to keratin, which causes hypersensitivity in the host 
(88), because they are retained in the body after antibodies form. Keratin is a 
fibrous protein characterized by its high content of lysine, arginine, and histidine
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(435). Differences in response of eosinophils to various groups of amino acids 
are indicated in the report of Harris and Lange (244) who found that only the 
dicarboxylic amino acids decrease eosinophils in normal animals.
X  I rradiation
Results of using several types of the so-called protective measures against 
X irradiation suggest that granulocytes may be an important factor in postir- 
radiation recovery (112). Bone marrow, blood, spleen, and other tissues which 
have protective or ameliorating effects against irradiation sickness are the tissues 
in which eosinophils, neutrophils, and platelets are formed or stored.
The peroxidase-containing cells appear to be important in recovery from ex­
posure to irradiation. Peroxidase has been reported to be absent in the marrow 
of leg bones of dogs and rabbits at, or near, death resulting from neutron radiation 
(631), whereas catalase activity in the rabbits was not affected, but was decreased 
in the irradiated dogs. That heterophils are important in postirradiation recovery 
was fairly conclusively demonstrated by experiments in which lethally irradiated 
rats were joined in parabiosis with nonirradiated rats. This series of experiments 
showed that depleting the heterophil leukocytes in the nonirradiated partner, 
by intravenous injection with myleran (20 mg/kg), resulted in all the irradiated 
partners (700 r) dying, whereas 60 per cent of the lethally irradiated parabionts 
which were joined to nonirradiated partners survived (509). Jacobson (278) 
summarized the facts indicating that humoral factors are active in the protective 
measures, such as spleen-shielding, intraperitoneal implantation of splenic tissue 
and suspensions of embryos, or intraperitoneal or intravenous injection of homol­
ogous bone marrow suspensions, and related techniques.
Ting and Zirkle, 1940, hold that leukocytes are radioresistant in contrast to 
mature lymphoid cells which are very radiosensitive (287). Cells in the erythrocytic 
series are also considered by Bloom and Bloom, 1947, to be more sensitive to 
irradiation than those in the leukocytic series (46). The presence of peroxidase 
may account for the greater resistance of granulocytes to irradiation. Mature 
granulocytes are quite resistant and are not directly affected by irradiation in 
any except excessive doses (433).
Many conditions, such as dosage and extent of X  irradiation, time after irradia­
tion, and presence or absence of infection, alter the number of neutrophils and 
eosinophils in the blood. It is not possible, therefore, to determine definitely the 
significance of peroxidase granules in relation to H2O2 production. George and 
Irvine (204) consider that the reaction of peroxidase, catalase, and other hemo- 
proteins with peroxides suggests interesting connections with problems in ionizing 
radiation. Other investigators hold that the protective mechanism may involve 
removal of free radicals and inhibition of enzyme activity (12), which Dale, 1940,
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has attributed to radiation products of water (32). However, Woodward (631) 
observed that peroxide was not present in the bone marrow of animals which were 
near death or died following neutron irradiation, and that peroxidase was much 
greater in the bone marrow of normal animals.
Peroxidase in the cytoplasm of the neutrophils and eosinophils in the bone mar­
row, spleen, and blood may have a beneficial effect in catalyzing oxidations utiliz­
ing H2O2 formed following irradiation. It has been suggested that formation of 
H2O2 is the most important of the primary reactions of X  irradiation (67), and 
it is held to be an important factor in X  ray toxicity (67, 185). Philpot, 1956, 
points out that organic peroxides as well as hydrogen peroxide are produced in 
cells by irradiation (22, 566); however, Horgan and Philpot (267) state that 
Dubouloz, Dumas, and Vigne, 1950, and Dubouloz and Dumas, 1952, are the 
only investigators who have found organic peroxides in irradiated animals. 
Barron (32) apparently holds that the H 20 2 produced in animals by X  irradiation 
results from its ionic effects on oxygen-saturated tissue water, for he found that 
X  irradiation in the absence of O2 failed to produce any H20 2 under controlled 
conditions. Radiation-produced H2O2 is a most effective agent in inhibiting tissue 
metabolism (32), and production of free hyperperoxide radicals HO2 results in 
excessive oxidations not due solely to H2O2 (566).
X  irradiation has been considered to cause formation of H20 2 directly and in­
directly. Allen, 1948, proposed that X  irradiation of water resulted in formation 
of hydrogen and hydrogen peroxide molecules and also in formation of hydrogen 
and hydroxyl radicals, which could convert the Ho and H202 molecules back to 
water (126). Bonet-Maury and Lefort, 1950, reported that the amount of oxygen 
dissolved in water, in addition to the amount of X  irradiation, temperature, pH, 
and electrolytes, determines the amount of hydrogen peroxide formed by irradia­
tion (32). Formation of H2O2 was considered to have little effect on biological 
systems because addition of electrolytes, protein or Fe++ ions significantly de­
creased the amount of H20 2 formed by X  irradiation of water (34). However, 
Dainton (126) states that the presence of highly reactive solutes, such as Fe44" 
in high concentrations, is not likely to cause great reduction in the yield of H2 
and H20 2 .
Many of the methods of protection against irradiation are directed against 
decreasing H 20 2 or its detrimental effects. Jolly, 1924, showed that ischemia 
reduced the effect of irradiation (46). Formation of peroxide after irradiation 
has been considered a harmless means of dissipating energy absorbed from radia­
tion (310). Irradiation at low oxygen tension inhibited the reduction in number 
of cells and of DNA synthesis in bone marrow (456) and thus had a protective 
property in the rat. Absence of oxygen in irradiated water has been shown by Patt 
and Brues, 1954, to prevent formation of H20 2 (32, 265). Anoxia has also been
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reported to protect mice against some of the injurious effects of radiation (205) 
and against death of cells as indicated by pycnosis of small lymphocytes (124). 
The protective effects of p-aminopropiophenone (PAPP), which reduces the 
mortality rate in irradiated mice and rats, is attributed to hypoxia resulting from 
methemoglobinemia formed by preirradiation administration of PAPP (124). 
The protective effects of preirradiation injections of serotonin into rats receiving 
total body X  irradiation has also been attributed to temporary tissue anoxia (228). 
Attempts to decrease cellular oxidations by action of thiouracil on the thyroid 
and thereby inhibit effects of irradiation were unsuccessful (67).
Sh ielding
The mechanism by which shielding hematopoietic tissue or injecting hema­
topoietic tissue affords protection for animals receiving lethal dosage of irradia­
tion has not been determined. Peroxidase occurs in neutrophils, eosinophils 
and their stem cells, and in blood platelets. Imprints of bone marrow, blood, spleen, 
liver, lymph nodes, pancreas, kidney, adrenal, and testis of normal, adult ham­
sters were stained by Graham's oxidase method. The only tissues in which signifi­
cant quantities of peroxidase occurred were the bone marrow and spleen. The 
localization of peroxidase in these tissues occurred in leukocytes and platelets 
and to a very small extent in cytoplasm of the megakaryocytes. Furthermore, 
the sparse peroxidase granules detected in other tissues occurred in the leuko­
cytes. The amount of peroxidase in the spleen of adult hamsters was increased 
under the conditions of extramedullary hematopoiesis induced by implanted 
tumors or by pregnancy (301, 302, 305).
The protective effect of shielding the spleen of irradiated mice has been at­
tributed to preservation of its hematopoietic function (463). A single intraperi­
toneal injection of a spleen-homogenate, representing the equivalent of 1 to 2 
spleens, administered 1 to 45 hours after irradiation decreased mortality of adult 
mice exposed to total body X  irradiation of 650, 700, and 800 r. The protective 
factor was more abundant in the spleen of mice 1 to 3 weeks old than of adult 
mice (110). One group of investigators reported that implantation of fresh spleen 
increased survival in mice after 1,025 r of X  irradiation (281); other investigators 
reported that they obtained negative results by implantation of fresh spleen (67); 
still another group found that postirradiation injection of spleen homogenate 
(1-45 hours) as a single, intraperitoneal dose decreased loss in weight of mice (110).
The greater number of eosinophils and neutrophils in the spleen than in the 
thymus and lymph nodes may explain the greater radioresistance of the spleen 
reported by Warren and Dunlap, 1942 (495). In addition, part of the beneficial 
effect of spleen shielding may be due to increasing resistance against infection, 
for it was noted that resistance to experimental infection with Pseudomonas was
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related to leukocyte count in irradiated mice and that the association "depends 
upon granulocyte count with no measurable lymphocyte contribution" (544) 
Thus, either granulocytes or specific constituents of the recovery more closely 
linked with granulocytic than with lymphocytic recovery were held to be re­
sponsible for the observed association. This indicated that the recovery factor 
was linked to granulocytic recovery rather than to lymphocytic (544). Other 
investigators, using low dosage (25-100 r) of X  irradiation of dogs, support this 
idea by suggesting that under conditions of their experiments total body irradia­
tion leads to maturation of white cells in the bone marrow with subsequent re­
lease of "band neutrophils into the peripheral blood stream" (455). It has been 
suggested that megakaryocytes play an important part in recovery since in­
jection of lethally irradiated mice with rat bone marrow is followed by the ap­
pearance and persistence of rat platelets in the peripheral blood of the mice (543) 
Campbell and Ross (89) injected lymphocytes into irradiated rats and concluded 
that the protection afforded by Jacobson's method of shielding the spleen "is 
probably due to a substance related to another cell", or, possibly, it may be that 
the transfused lymphocytes, though motile for some time, were fatally injured 
or that those obtained from the mesenteric ducts differ from splenic lymphocytes.
Injection of bone marrow from mice into inbred and hybrid mice and into guinea 
pigs induced an immediate protective effect on these animals, and the homologous 
bone marrow grew luxuriantly in the omentum following intraperitoneal or 
intravenous injection (355). It was suggested that the mode of protection afforded 
by injection of the heterologous bone marrow was humoral, or non-cellular, while 
the superior protection produced by the homologous marrow was the result of 
summated humoral and a cellular factor (355), but these investigators did not 
suggest how these factors hastened recovery. Lorenz and Congdon (354) obtained 
comparable results by transplanting cleaned, marrow-free bone of rats and mice 
intraperitoneally into mice. The homologous bone transplants produced marrow 
but the heterologous grafts did not; however, both types of bone transplantation 
protected mice from lethal X  irradiation.
Shielding ectopically induced marrow has been shown to increase survival 
from exposure to total body X  irradiation of 650 r, but shielding the in situ fatty 
marrow did not increase survival (560). However, Simmons, et al. (532) noted 
that daily injections of yellow bone marrow (Armour's preparation) into non- 
irradiated rabbits increased the initial rise in leucocyte, heterophil, and lymphocyte 
count up to 16 days, after which the count fell to below that of normal, non- 
irradiated control animals. In other work with rabbits, daily injection of yellow 
bone marrow up to 6 days prior to 600 r exposure and during 14 days postirradia- 
tion did not deter the postirradiation fall in heterophil count (532). Other in­
vestigators apparently (543) attribute the beneficial results of injecting rat bone
PEROXIDASE IN EOSINOPHILS 89
marrow into lethally irradiated mice to the appearance of rat blood platelets and 
their persistence in the peripheral blood of the mice.
The effect of bone marrow transplant differs in several species of mammals. 
Reckers, et al., 1949, 1950, reported that transplants of bone marrow do not 
alter recovery in dogs; and Talbot and Pinson, 1951, in rats (433). However, 
if rats have a small area of the intestine shielded by applying a lead belt }/$ inch 
wide or shielding the exteriorized intestine with sheet lead and are then intra­
venously injected with 30 mg of bone marrow per 100 gm of body weight, their 
tolerance is trebled over the effect of shielding intestine alone (572). Intravenous 
or intraperitoneal administration of bone marrow into guinea pigs and mice has a 
protective effect, as Lorenz, et ah, 1951, 1952, have shown (433). Intravenous 
injections of bone marrow emulsion or of its supernatant fraction into rabbits 3 
days after exposure to total body X  irradiation of 1200 r increased 30-day survival 
from 20 to 60 per cent (259). Mice are protected from effects of irradiation by 
implants of rat bone marrow, but do not form bone marrow (354). Isologous bone 
marrow cells after being incubated at 25 C for 24 days also prevented death in a 
lethally irradiated strain of mice (54).
Protection or injection of bone marrow apparently has some beneficial effect 
on lymphoid tissue because shielding red bone marrow or intravenously injecting 
"normal isologous marrow cells" strikingly inhibits production of lymphoid 
tumors in mice (296). The factor in bone marrow which is responsible for thymic 
regeneration apparently is strain-specific in action, for shielding the thigh of 
several strains of mice during total irradiation or injection of isologous bone 
marrow consistently increased regeneration of the thymus, whereas heterologous 
or homologous marrow was ineffective (261). In evaluating effects on the thymus, 
it is necessary to recognize whether the gonads are functioning or have been per­
manently damaged. The thymus of hamsters that survived 18 to 30 days after 
995 r was considerably larger than that of normal hamsters of the same age and 
sex. The absence of spermatogenesis in the testis would be expected to cause 
hypertrophy of the thymus in view of the function of the thymus being a DNA- 
histone storage organ until the gonads function. The greater increase in lym- 
phocytopoiesis and of nucleoprotein synthesis and storage in the thymus of 
irradiated animals which had non-functioning gonads might be related to develop­
ment of lymphoid leukemia (305).
X irradiation affects the number of leukocytes in the blood. It is necessary to 
recognize that initial effects of irradiation are not the same as later effects and 
that the stimuli which evoke a transient (prolonged and extensive) leukocytosis 
can also cause depletion of bone marrow. Various changes in leukocytes have 
been reported after irradiation. Lawrence and co-workers found an increase in 
eosinophils for part of the first 48 hours after 300 r total-body X  irradiation of
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dogs (123). Aubertin and Beaujard, 1908, also reported an increase in eosinophils 
after irradiation (279). Leukocytosis following exposure of rabbits to 500 r or 
more of X  irradiation is due entirely to increased numbers of heterophils (280).
An initial leukocytosis followed by leukopenia has been reported in man (280, 
516), in rats (163) and other animals after total body X  irradiation over 100 r. 
Patt and Brues (433) state that the heterophils or granulocytes are the only cir­
culating cells which were initially increased numerically and that eosinophils, 
as well as the lymphocytes, monocytes, reticulocytes, and platelets, were invariably 
reduced after acute X  irradiation. Relation of various types of irradiation dosage 
and of acute and accumulative chronic poisonings of several mammals has been 
thoroughly summarized (10). Neutropenia, as well as decreases in other bone 
marrow derivatives, is due to the destruction of bone marrow that follows various 
forms of irradiation (163, 497).
Several explanations for the beneficial effects of protecting and promoting re­
sumption of hematopoiesis after irradiation are given. The beneficial effect of 
spleen and bone marrow cells injected into irradiated mice and hamsters has 
been attributed to the promotion of early recovery of the granulocytes (368), 
while the beneficial effect of parabiosis in irradiated leucopenic rats with a non- 
irradiated parabiont has been attributed to the passage of blood cells from the 
nonirradiated partner across capillary anastomoses (391). Granulocytes trans­
fused into irradiated dogs having aplastic bone marrow migrated to infection sites 
(73). Some of the beneficial effects of sulfhydryl compounds have been attributed 
to protection of blood granulocytes and their precursors in the bone marrow 
(124). Protection obtained by injecting chemicals is attributed to the protection 
"afforded the bone marrow count" as shown by the rapid recovery of the bone 
marrow counts in mice exposed to as much as 900 r of X  irradiation (598).
The blood eosinophilia following irradiation may also be a response to increased 
protein catabolism produced by lysis of small lymphocytes. As early as 1907, 
Edsall and Pemberton considered the toxic reaction of lysis of tissue as a cause 
of clinical radiation sickness (433). Lymphocytes, which are considered one of 
the most, if not the most, sensitive cells to irradiation (65, 123, 280, 433, 582, 627) 
disintegrate very rapidly. Barrow and Tullis (35) reported fragmentation and 
lysis of lymphoid cells one hour after irradiation and Cramer, Drew, and Mot- 
tram (121) state that the first change after exposure to X  rays was a decrease in 
the circulating leukocytes. Released histamine and other substances or formation 
of products from cytolyzed lymphocytes might be a cause for the initial eosino­
philia. X  irradiation does not cause extensive lysis of plasmacytes as it does of 
lymphocytes. Part of the difference may be due to the greater amount of RNA 
in the cytoplasm of these cells, and to a protective effect on the inhibitor or a 
deterrent effect of RNAase because H 202 and oxidized glutathione have been
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reported to inhibit activity of RNAase (338). Campbell and Ross (89) injected 
lymphocytes of rats made lymphopenic by X  rays and found that there were 
fewer neutrophils in the lymph-injected group. If some of these lymphocytes and 
the protein in the injected lymph underwent lysis, the amount of extracellular 
H2O2 would be increased, and if this provoked release of peroxidase granules 
from neutrophils, neutropenia would be an expected result rather than a seeming 
discrepancy.
Stimulation of hematopoiesis by several methods has beneficial effects on 
irradiation sickness. Pentnucleotide in 5.0 ml doses administered after irradiation 
caused higher leukocyte counts on the third day in rabbits, but daily injection 
of 5.0 ml during 14 days preceding exposure to 600 r had no beneficial effect al­
though lymphocytes were increased 5 to 9 days after irradiation (532). Preirradia­
tion stimulation of hematopoiesis with estrogens increased recovery of granulo­
cytopenia in irradiated mice (433). The beneficial effects of glutathione has been 
considered to be due to protection of the control mechanism for hematopoiesis 
(124); however, stimulation of erythropoiesis by feeding a cobalt supplemental 
diet has not been found beneficial and has been considered detrimental to recovery 
when given in polycythenic doses (113). Apparently stimulation of erythropoiesis 
by cobalt may not be due directly to cobalt ions, but to stimulation of the forma­
tion of erythropoietin and does not increase leukopoiesis (218). There are several 
possible "delayed" causes of irradiation sickness that pertain to formation of 
peroxides. Autoxidation of unsaturated fatty acid chains after X  irradiation causes 
formation of H2O2, which develops more rapidly after irradiation because of the 
destruction of antioxidants (243). The ameliorating effects of azide and cyanide 
has been attributed to inhibition of catalase which may form a catalase-inhibitor 
complex that is more stable to effects of radiation than uncomplexed catalase 
(184). Resistance of bacteria to irradiation is increased by catalase, which, how­
ever, loses its effect in the presence of formate (103).
Various explanations of the mechanism for the beneficial effects of compounds 
containing SH groups have been given. However, most of these means counteract 
effects of oxidative changes. Reactivation of enzymes containing SH groups in 
the protein moiety has been considered the mechanism for the beneficial effect 
of glutathione administered after small or moderate amounts of X  ray dosage 
(33). Preradiation treatment with glutathione has also been reported to increase 
survival time (196). Barron (32) strongly supports these findings by stating that 
addition of glutathione gives "complete protection of the enzyme". Preirradiation 
injections of mice with cysteamine or cystamine mitigated the lethal effects of 
1100 r total-body X  irradiation, and this protective effect was increased in mice 
rendered hypoxic before and during the irradiation (135). Other investigators 
(432) found that addition of cysteine to a suspension of rabbit thymocytes de­
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creased the sensitivity of these cells to X  rays over a wide range of dosage. When 
the thymocytes were packed in vitro, cysteine failed to protect them, and this 
failure is suggested as being a consequence of hypoxia resulting from competition 
with the cell substrate for oxygen. Later, it was found that cysteinamine is 5 
times as effective as cysteine when equimolar amounts are administered intra­
venously prior to X  irradiation (561). Formation of a temporary disulfide linkage, 
which is more resistant to ionizing radiation than the "unprotected" sulfhydral 
group, can be restored by normal processes and is considered to be the protective 
mechanism of cystamine (352). A single intravenous injection of cysteins (950 mg/ 
kg) 5 minutes prior to total body X  irradiation (88 r) decreased the effects on 
the hematopoietic system and hastened recovery in rats (434), as well as de­
creasing other lethal effects (541). Preirradiation addition of cysteine in vitro 
also inhibited the expected decrease in viscosity of alkaline solutions of nucleo- 
proteins subjected to X  radiation (191).
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